Document is current
Any future updates will be listed below
-
Authors
Chevalier, Laurent
Cochet, Hubert
Mahida, Saagar
S, Sylvain Blanchard
Benard, Antoine
Cariou, Tanguy
Sridi-Cheniti, Soumaya
Benhenda, Samy
Doutreleau, Stéphane
Cade, Stéphane
Guerard, Sylvain
Guy, Jean-Michel
Trimoulet, Pascale
Picard, Stéphane
Dusfour, Bernard
Pouzet, Aurelie
Roseng, Stéphanie
Franchi, Marco
Jaïs, Pierre
Pellegrin, Isabelle
,
Chevalier, Laurent
Pellegrin, Isabelle
Babeau, Michel
Bensaïd, Akram
Bernard, Jeremy
Blanchard, Sylvain
Chadourne, Cédric
Claisse, Patrick
Cubillé, Victor
Dindart, Jean-Michel
Franchi, Marco
Goguillot, Sophie
Humetz, Ludovic
Izard, Philippe
Laffourcade, Benjamin
Lemahieu, Bernard
Monnot, Damien
Poirier, Cédric
Pouget, Philippe
Rebeyrol, Jean-Louis
Rubio, Elliot
Vela, Carlos
Vincent, Quentin
- License Information
-
More Information
Article History
Received: 18 February 2022
Accepted: 2 May 2022
First Online: 25 June 2022
Declarations
:
: Written informed consent was obtained from all participants. The study was approved by the Ethics Committee (Toulouse, SUD-OUEST ET OUTRE-MER II, ID-RCB: 2020-A01196-33).
: All authors have provided consent for publication.
: Abbott has kindly provided the anti-SARS-CoV-2 serology tests (IgG and IgM) to the biology department of the Bordeaux University Hospital (I. Pellegrin, S. Picard, P. Trimoulet) for centralized serologies. The other authors declare that they have no competing interests.
